Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease.

Shams R, Banik NL, Haque A.

Prog Mol Biol Transl Sci. 2019;167:107-124. doi: 10.1016/bs.pmbts.2019.06.007. Epub 2019 Aug 19.

PMID:
31601400
2.

Marion Edmonds Smith (1926-2017).

Boullerne AI, Benjamins JA, Chiu A, Banik NL.

J Neurochem. 2019 Jan;148(2):164-167. doi: 10.1111/jnc.14611. Epub 2018 Dec 13. No abstract available.

3.

A Missing Link between Neuron Specific Enolase Release and Poor Prognosis in Aging Patients with B-cell Lymphoma.

Polcyn R, God J, Capone M, Matzelle D, Banik NL, Haque A.

J Clin Cell Immunol. 2018;9(3). pii: e121. doi: 10.4172/2155-9899.1000e121. Epub 2018 May 15. No abstract available.

4.

Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report.

Chandran R, Capone M, Matzelle D, Polcyn R, Kau E, Haque A, Banik NL.

Neurochem Res. 2018 Dec;43(12):2224-2231. doi: 10.1007/s11064-018-2655-z. Epub 2018 Oct 5.

PMID:
30291537
5.

New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection.

Haque A, Polcyn R, Matzelle D, Banik NL.

Brain Sci. 2018 Feb 18;8(2). pii: E33. doi: 10.3390/brainsci8020033. Review.

6.

Neuron specific enolase is a potential target for regulating neuronal cell survival and death: implications in neurodegeneration and regeneration.

Polcyn R, Capone M, Hossain A, Matzelle D, Banik NL, Haque A.

Neuroimmunol Neuroinflamm. 2017;4:254-257. doi: 10.20517/2347-8659.2017.59. Epub 2017 Dec 6. No abstract available.

7.

Enolase and Acute Spinal Cord Injury.

Polcyn R, Capone M, Hossain A, Matzelle D, Banik NL, Haque A.

J Clin Cell Immunol. 2017;8(6). pii: 536. doi: 10.4172/2155-9899.1000536. Epub 2017 Dec 29. No abstract available.

8.

A Novel Aza-MBP Altered Peptide Ligand for the Treatment of Experimental Autoimmune Encephalomyelitis.

Trager NNM, Butler JT, Harmon J, Mount J, Podbielska M, Haque A, Banik NL, Beeson CC.

Mol Neurobiol. 2018 Jan;55(1):267-275. doi: 10.1007/s12035-017-0739-4.

9.

Albumin-Assisted Method Allows Assessment of Release of Hydrophobic Drugs From Nanocarriers.

Gil D, Frank-Kamenetskii A, Barry J, Reukov V, Xiang Y, Das A, Varma AK, Kindy MS, Banik NL, Vertegel A.

Biotechnol J. 2018 Jan;13(1). doi: 10.1002/biot.201700337. Epub 2017 Sep 25.

PMID:
28881095
10.

Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats.

Haque A, Capone M, Matzelle D, Cox A, Banik NL.

Neurochem Res. 2017 Oct;42(10):2777-2787. doi: 10.1007/s11064-017-2291-z. Epub 2017 May 15.

11.

Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation.

Miller LG Jr, Young JA, Ray SK, Wang G, Purohit S, Banik NL, Dasgupta S.

Neurochem Res. 2017 Oct;42(10):2755-2768. doi: 10.1007/s11064-017-2280-2. Epub 2017 May 5.

PMID:
28474276
12.

Correction: Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury.

Ray SK, Samantaray S, Banik NL.

Neural Regen Res. 2017 Feb;12(2):266. doi: 10.4103/1673-5374.200818.

13.

Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury.

Ray SK, Samntaray S, Banik NL.

Neural Regen Res. 2016 Sep;11(9):1418-1419. No abstract available. Erratum in: Neural Regen Res. 2017 Feb;12 (2):266.

14.

Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation.

Podbielska M, Das A, Smith AW, Chauhan A, Ray SK, Inoue J, Azuma M, Nozaki K, Hogan EL, Banik NL.

J Neurochem. 2016 Nov;139(3):440-455. doi: 10.1111/jnc.13774. Epub 2016 Oct 18. Erratum in: J Neurochem. 2018 Jan;144(2):234.

15.

Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis.

Smith AW, Rohrer B, Wheless L, Samantaray S, Ray SK, Inoue J, Azuma M, Banik NL.

J Neurochem. 2016 Oct;139(2):270-284. doi: 10.1111/jnc.13770. Epub 2016 Sep 27.

16.

Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.

Samantaray S, Das A, Matzelle DC, Yu SP, Wei L, Varma A, Ray SK, Banik NL.

J Neurochem. 2016 May;137(4):604-17. doi: 10.1111/jnc.13610. Epub 2016 Apr 12.

17.

Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.

Haque A, Ray SK, Cox A, Banik NL.

Metab Brain Dis. 2016 Jun;31(3):487-95. doi: 10.1007/s11011-016-9801-6. Epub 2016 Feb 5. Review.

18.

RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma.

Das A, McDonald DG, Dixon-Mah YN, Jacqmin DJ, Samant VN, Vandergrift WA 3rd, Lindhorst SM, Cachia D, Varma AK, Vanek KN, Banik NL, Jenrette JM 3rd, Raizer JJ, Giglio P, Patel SJ.

Tumour Biol. 2016 Jun;37(6):7525-34. doi: 10.1007/s13277-015-4621-6. Epub 2015 Dec 18.

PMID:
26684801
19.

Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats.

Samantaray S, Das A, Matzelle DC, Yu SP, Wei L, Varma A, Ray SK, Banik NL.

J Neurochem. 2016 Mar;136(5):1064-73. doi: 10.1111/jnc.13464. Epub 2016 Jan 26.

20.

Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma.

Das A, Cheng RR, Hilbert ML, Dixon-Moh YN, Decandio M, Vandergrift WA 3rd, Banik NL, Lindhorst SM, Cachia D, Varma AK, Patel SJ, Giglio P.

Cancer Growth Metastasis. 2015 Dec 1;8:51-60. doi: 10.4137/CGM.S32801. eCollection 2015.

Supplemental Content

Loading ...
Support Center